Kitajima I - Search Results

Year	Number of Results
1961	1
1985	1
1986	6
1987	3
1988	5
1989	5
1990	5
1991	3
1992	3
1993	3
1994	8
1995	6
1996	9
1997	9
1998	5
1999	10
2000	8
2001	12
2002	7
2003	8
2004	5
2005	13
2006	10
2007	7
2008	3
2009	5
2010	4
2011	7
2012	5
2013	5
2014	10
2015	7
2016	7
2017	3
2018	6
2019	6
2020	5
2021	11
2022	17
2023	10
2024	7
2025	4

1

Periostin activates distinct modules of inflammation and itching downstream of the type 2 inflammation pathway.

Nunomura S, Uta D, Kitajima I, Nanri Y, Matsuda K, Ejiri N, Kitajima M, Ikemitsu H, Koga M, Yamamoto S, Honda Y, Takedomi H, Andoh T, Conway SJ, Izuhara K. Nunomura S, et al. Among authors: kitajima i. Cell Rep. 2023 Jan 31;42(1):111933. doi: 10.1016/j.celrep.2022.111933. Epub 2023 Jan 6. Cell Rep. 2023. PMID: 36610396 Free PMC article.

2

Inhibitors of Factor XIII/13 in older patients.

Ichinose A; Japanese Collaborative Research Group (JCRG) on AH13 Hemorrhagic Acquired Coagulopathies. Ichinose A, et al. Semin Thromb Hemost. 2014 Sep;40(6):704-11. doi: 10.1055/s-0034-1390151. Epub 2014 Sep 12. Semin Thromb Hemost. 2014. PMID: 25215637 Review.

3

New Possibilities for Evaluating the Development of Age-Related Pathologies Using the Dynamical Network Biomarkers Theory.

Akagi K, Koizumi K, Kadowaki M, Kitajima I, Saito S. Akagi K, et al. Among authors: kitajima i. Cells. 2023 Sep 17;12(18):2297. doi: 10.3390/cells12182297. Cells. 2023. PMID: 37759519 Free PMC article. Review.

4

[Molecular pathomechanism of HTLV-I infectious diseases].

Kitajima I. Kitajima I. Rinsho Byori. 1997 Nov;45(11):1048-56. Rinsho Byori. 1997. PMID: 9396344 Review. Japanese.

5

[Chairmen's Introductory Remarks].

Matsumoto H, Kitajima I. Matsumoto H, et al. Among authors: kitajima i. Rinsho Byori. 2016 Aug;64(8):895-897. Rinsho Byori. 2016. PMID: 30609327 Japanese.

6

Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B.

Kitajima I, Shinohara T, Bilakovics J, Brown DA, Xu X, Nerenberg M. Kitajima I, et al. Science. 1992 Dec 11;258(5089):1792-5. doi: 10.1126/science.1299224. Science. 1992. PMID: 1299224

7

[Carboxy-terminal propeptide of type I procollagen (PICP)].

Tanaka Y, Kitajima I. Tanaka Y, et al. Among authors: kitajima i. Nihon Rinsho. 2004 Dec;62 Suppl 12:244-6. Nihon Rinsho. 2004. PMID: 15658310 Review. Japanese. No abstract available.

8

Type I muscle atrophy caused by microgravity-induced decrease of myocyte enhancer factor 2C (MEF2C) protein expression.

Yamakuchi M, Higuchi I, Masuda S, Ohira Y, Kubo T, Kato Y, Maruyama I, Kitajima I. Yamakuchi M, et al. Among authors: kitajima i. FEBS Lett. 2000 Jul 14;477(1-2):135-40. doi: 10.1016/s0014-5793(00)01715-4. FEBS Lett. 2000. PMID: 10899324 Free article.

9

[Direct Oral Anticoagulants (DOACs): Pharmacological Characteristics and Laboratory Assessment].

Kitajima I. Kitajima I. Rinsho Byori. 2016 Aug;64(8):972-979. Rinsho Byori. 2016. PMID: 30609341 Review. Japanese.

10

[Pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen (ICTP)].

Tanaka Y, Kitajima I. Tanaka Y, et al. Among authors: kitajima i. Nihon Rinsho. 2004 Dec;62 Suppl 12:240-3. Nihon Rinsho. 2004. PMID: 15658309 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

258 results

Results by year